Oncolytics Biotech (ONCY) Cash from Discontinued Operations (2017 - 2019)
Oncolytics Biotech's (ONCY) quarterly Cash from Discontinued Operations came in at 4748578.0 in Q2 2019, down 905.85% year-on-year from 589264.0 in Q2 2018, and down 905.85% on a QoQ basis from 589264.0 in Q2 2018.
Oncolytics Biotech (ONCY) Cash from Discontinued Operations (2017 - 2019) Analysis & Trends
Oncolytics Biotech (ONCY) has 3 years of Cash from Discontinued Operations data on file, last reported at 4748578.0 in Q2 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Discontinued Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,681.27 Bn | 66,680.98 Bn | - | - |
| 2 | Nanobiotix | 1,905.61 Bn | 1,905.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,011.81 Bn | 1,011.81 Bn | - | - |
| 4 | BeOne Medicines | 467.29 Bn | 462.50 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 122.89 Bn | 115.65 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 70.28 Bn | 61.53 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.93 Bn | 62.93 Bn | - | - |
| 8 | Argenx Se | 55.90 Bn | 50.72 Bn | 1.41 Bn | - |
| 9 | Alnylam Pharmaceuticals | 37.64 Bn | 34.63 Bn | 959.66 Mn | - |
| 10 | Oncolytics Biotech | 76.67 Mn | 76.67 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2019 | -4.75 Mn |
| Jun 30, 2019 | -4.75 Mn |
| Jun 30, 2018 | 589,264.00 |
| Jun 30, 2018 | 589,264.00 |
| Jun 30, 2017 | -4.55 Mn |
| Jun 30, 2017 | -4.55 Mn |